reglab/statecodes huggingface dataset:
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 270.000 - Blood Screening Of Newborns For Treatable Diseases And Disorders › Section 270.012 - Storage and Use of Residual Specimens and Data

Current through Register 1525, July 5, 2024
(A) Residual specimens and data shall be
			 retained, stored, used, and destroyed by the Newborn Screening Program only in
			 accordance with the Massachusetts Department of Public Health Policy on the
			 Retention, Storage and Use of Newborn Screening Data and Residual
			 Specimens.
(B) Except as provided
			 in 105 CMR 270.012(C), the Newborn Blood Screening Program shall retain and use
			 residual specimens for a minimum of 15 years and a maximum of 16 years for the
			 purposes of:
(1) Laboratory Quality
			 Assurance, including laboratory quality control, laboratory validation,
			 participation in proficiency testing, and the practice of continuous quality
			 improvements;
(2) Individual or
			 family clinical benefit;
(3)
			 Individual or family forensic purposes;
(4) Uses authorized by law;
(5) Research studies approved by the
			 Department or UMMS Institutional Review Board provided that a residual specimen
			 is not provided to a researcher without the written consent of the parent or
			 guardian for specimens collected on or after March 16, 2015. The IRB retains
			 discretion to require consent for use of any stored residual specimen for any
			 particular research study.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 271.000 - Postpartum Depression Screening And Reporting › Section 271.002 - Scope

Current through Register 1525, July 5, 2024
105 CMR 271.000 applies
				to:
(A) a Provider that conducts or
			 oversees screening for postpartum depression during a clinical encounter with a
			 woman who has given birth within six months when she presents as a patient;
			 and
(B) a Carrier that receives a
			 claim for a postpartum depression screening.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 271.000 - Postpartum Depression Screening And Reporting › Section 271.004 - Responsibilities of Providers

Current through Register 1525, July 5, 2024
(A) A Provider that
			 conducts or oversees for screening of a woman who has given birth within six
			 month for postpartum depression is mandated to report data regarding such
			 postpartum screening on an annual basis by March 1st
			 for the previous calendar year using a method specified in 105 CMR
			 271.004(C).
(B) A Provider that is
			 part of a Provider group or a Provider Organization may report through such
			 Provider group or, at the discretion of their Provider Organization, through
			 such Provider Organization.
(C) A
			 Provider shall report to the Department using one of the following methods of
			 reporting:
(1) Directly through submission of
			 an annual report to the Department no later than March
			 1st for the previous calendar year using a form or
			 electronic format specified by the Commissioner and in accordance with
			 guidelines issued by the Commissioner; or
(2) Indirectly through submission of
			 reportable claims to Carriers on an ongoing basis in accordance with applicable
			 guidelines issued by the Commissioner, in consultation with the Center for
			 Health Information and Analysis, regarding requisite code(s), mechanisms and
			 deadlines for the reporting. A reportable claim means a claim for screening
			 services delivered by a Provider to a postpartum patient during a given
			 calendar year for which an annual report would be otherwise be due for
			 submission to the Department under 105 CMR 271.004(A). A Provider that submits
			 reportable claims to Carriers in accordance with 105 CMR 271.004(C)(2) is
			 encouraged to submit reportable claims to third-party administrators (TPA) or
			 administrative service-only organizations (ASO) when such TPA or ASO permits
			 the claims to be reported in accordance with the Commissioner's applicable
			 guidelines.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 271.000 - Postpartum Depression Screening And Reporting › Section 271.005 - Responsibilities of Carriers

Current through Register 1525, July 5, 2024
A Carrier shall report data regarding postpartum screening
				conducted by Providers on an annual basis by March
				1st for the previous calendar year to the Department
				using one of the following methods of reporting:
(A) Directly through submission of an annual
			 report to the Department no later than March 1st for
			 the previous calendar year using a form or electronic format specified by the
			 Commissioner and in accordance with guidelines issued by the Commissioner;
			 or
(B) Indirectly through
			 submission of reportable claims to the Center for Health Information and
			 Analysis on an ongoing basis in accordance with applicable guidelines issued by
			 the Commissioner, in consultation with the Center for Health Information and
			 Analysis, regarding requisite code(s), mechanisms and deadlines for the
			 reporting. A reportable claim means a claim for postpartum screening services
			 covered by the Carrier in accordance with the Carrier's coverage and payment
			 policies during a given calendar year for which an annual report would
			 otherwise be due for submission to the Department under
			 105 CMR
			 271.004(A).
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 271.000 - Postpartum Depression Screening And Reporting › Section 271.006 - Severability

Current through Register 1525, July 5, 2024
The provisions of
				105 CMR 271.000 are
				severable. If any provision or application thereof is held to be invalid by a
				court of competent jurisdiction, such invalidity will be severed and will not
				affect the remainder of
				105 CMR
				271.000.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 300.000 - Reportable Diseases, Surveillance, and Isolation and Quarantine Requirements › Section 300.001 - Purpose

Current through Register 1525, July 5, 2024
The purpose of
				105 CMR 300.000 is to list
				diseases dangerous to the public health as designated by the Department of
				Public Health and to establish reporting, surveillance, isolation and
				quarantine requirements.
				105 CMR 300.000 is intended
				for application by local boards of health, hospitals, laboratories, physicians
				and other health care workers, veterinarians, education officials, recreational
				program health service providers, food industry officials, and the
				public.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 300.000 - Reportable Diseases, Surveillance, and Isolation and Quarantine Requirements › Section 300.050 - Disease Surveillance and Case Management System

Current through Register 1525, July 5, 2024
The Department shall maintain MAVEN to: receive reports of
				disease events; collect clinical, demographic and epidemiologic data; conduct
				surveillance (also known as monitoring) for diseases; conduct investigations;
				respond to and control diseases dangerous to the public health. Local boards of
				health shall have MAVEN access for these purposes according to their
				jurisdiction. Where necessary for the investigation, monitoring, control or
				prevention of diseases dangerous to the public health, the Department may
				designate other individuals as able to access MAVEN. Access so designated by
				the Department shall be strictly limited to such necessity.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 300.000 - Reportable Diseases, Surveillance, and Isolation and Quarantine Requirements › Section 300.110 - Case Reports by Local Board of Health

Current through Register 1525, July 5, 2024
Each local board of health shall report to the Department the
				occurrence or suspected occurrence of any disease reported to the board of
				health, pursuant to
				105 CMR
				300.100. The case's full clinical data,
				demographic data and epidemiologic data, as defined by the Department, must be
				included for each report. Each local board of health shall utilize the secure
				electronic disease surveillance and case management system (MAVEN) designated
				and maintained by the Department. Each case shall be reported immediately, but
				no later than 24 hours after receipt by the local board of
				health.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 300.000 - Reportable Diseases, Surveillance, and Isolation and Quarantine Requirements › Section 300.120 - Confidentiality

Current through Register 1525, July 5, 2024
(A) All confidential personally identifying
			 information, whether kept in electronic system or paper format including, but
			 not limited to, reports of disease, clinical data, demographic data, and
			 epidemiological data, notes, and memoranda, about any individual that is
			 reported to or collected by the Department or local boards of health, or any
			 individual or entity designated by the Department in accordance with 105 CMR
			 300.050, pursuant to
			 105 CMR 300.000 shall,
			 unless disclosed as otherwise allowed in 105 CMR 300.120(A), be treated as
			 confidential. Only those employees of the Department, local boards of health,
			 or any individual or entity designated by the Department in accordance with 105
			 CMR 300.050, who have a specific need to review personal data records for the
			 purposes allowed herein or otherwise required by law shall be entitled access
			 to information contained in MAVEN and other such records. Any individual or
			 entity making or receiving a report of disease shall ensure all paper records
			 and electronic data systems related to information reported to or collected
			 pursuant to
			 105 CMR 300.000 are treated
			 as confidential in the same manner as information contained within MAVEN, kept
			 secure and to the greatest extent possible kept in controlled access areas.
			 Except when necessary for the Commonwealth's or local jurisdiction's disease
			 investigation, control, treatment and prevention purposes, or for studies or
			 research authorized by the commissioner pursuant to M.G.L. c. 111, § 24A,
			 the Department and local boards of health or any individual or entity
			 designated by the Department in accordance with 105 CMR 300.050, shall not
			 disclose any personally identifying information without the individual's
			 written consent.
(B)
			 Notwithstanding 105 CMR 300.120(A), the Department shall not disclose to the
			 federal government, the Commonwealth or any of its political subdivisions or
			 any agency, agent, or contractor of said Commonwealth or federal government,
			 the identity of any individual with HIV or AIDS reported to the Department
			 under
			 105 CMR 300.000.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 300.000 - Reportable Diseases, Surveillance, and Isolation and Quarantine Requirements › Section 300.131 - Illness Believed to Be Due to Food Consumption

Current through Register 1525, July 5, 2024
Every person who is a health care provider or who is in a
				supervisory position at a school, day care, hospital, institution, clinic,
				medical practice, laboratory, labor or other camp who has knowledge of the
				occurrence or suspected occurrence of case or cases of illness believed to have
				been due to the consumption of food, shall report the same immediately by
				telephone, by facsimile or other electronic means to the local board of health
				in the community in which the facility is located or the Department directly.
				If the Department is notified directly, it shall notify the local board of
				health within 24 hours.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 300.000 - Reportable Diseases, Surveillance, and Isolation and Quarantine Requirements › Section 300.132 - Illness Believed to Be Transmissible Through Food

Current through Register 1525, July 5, 2024
The manager or supervisor of any food handling facility, when
				he or she knows or has reason to believe that an employee has contracted any
				disease transmissible through food or has become a carrier of such disease,
				shall report the same immediately by telephone, by facsimile or other
				electronic means to the local board of health in the community in which the
				facility is located or the Department directly. If the Department is notified
				directly, it shall notify the local board of health within 24
				hours.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 300.000 - Reportable Diseases, Surveillance, and Isolation and Quarantine Requirements › Section 300.133 - Illness Believed to Be Unusual

Current through Register 1525, July 5, 2024
In addition to the diseases listed in
				105 CMR
				300.100, every person who is a health care
				provider or who is in a supervisory position at a school, day care, hospital,
				institution, clinic, medical practice, laboratory, labor or other camp,
				employers, or, if necessary, other entities determined by the Department, who
				has knowledge of the occurrence of a case or a suspect case of an unusual
				illness, shall report the same immediately by telephone, by facsimile or other
				electronic means to the local board of health in the community in which the
				facility is located or contact the Department directly. If the Department is
				notified directly, it shall notify the local board of health within 24
				hours.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 300.000 - Reportable Diseases, Surveillance, and Isolation and Quarantine Requirements › Section 300.134 - Illness Believed to Be Part of a Suspected or Confirmed Cluster or Outbreak

Current through Register 1525, July 5, 2024
In addition to the diseases listed in
				105 CMR
				300.100, every person who is a health care
				provider or who is in a supervisory position at a school, day care, hospital,
				institution, clinic, medical practice, laboratory, labor or other camp,
				employers, or, if necessary, other entities determined by the Department, who
				has knowledge of the occurrence of any suspected or confirmed cluster or
				outbreak of any illness, shall report the same immediately by telephone, by
				facsimile or other electronic means to the local board of health in the
				community in which the facility is located or contact the Department directly.
				If the Department is notified directly, it shall notify the local board of
				health within 24 hours.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 300.000 - Reportable Diseases, Surveillance, and Isolation and Quarantine Requirements › Section 300.135 - Reporting of Pediatric Influenza Deaths, Severe and Unusual Illness Due to Influenza, Cases of Antiviral Treatment or Prophylaxis Failure, and Illnesses Believed to Be Due to Novel Influenza Viruses

Current through Register 1525, July 5, 2024
(A)
			 Health care providers shall report to the Department within 24 hours, in a form
			 or manner deemed acceptable by the Department:
(1) All suspected and confirmed deaths due to
			 influenza in pediatric patients and in pregnant women. Pediatric patients are
			 defined as individuals younger than 18 years old;
(2) All suspect or confirmed human cases of
			 influenza that are unusual or unusually severe including, but not limited to,
			 cases with encephalopathy, myocarditis or pericarditis;
(3) All cases of influenza suspected or
			 proven to be a result of resistance to an influenza antiviral agent;
			 and
(4) Suspect or confirmed cases
			 of human infection due to influenza A viruses that are different from currently
			 circulating human influenza H1 and H3 viruses. These viruses include those that
			 are subtyped as nonhuman in origin and those that are unsubtypable with
			 standard methods and reagents.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 300.000 - Reportable Diseases, Surveillance, and Isolation and Quarantine Requirements › Section 300.136 - Reporting of Infection or Suspected Infection Believed to Be Transmitted by a Transfused Blood Product or Transplanted Organ, Tissue or Tissue Product

Current through Register 1525, July 5, 2024
In addition to the diseases listed in
				105 CMR
				300.100, every person who is a health care
				provider or who is in a supervisory position at a hospital, institution,
				clinic, medical practice, or laboratory, who has knowledge of the occurrence of
				a case or a suspect case of an infection or suspected infection that may be
				transmitted by a transfused blood product or transplanted organ, tissue, or
				tissue product, shall report the same immediately by telephone, by facsimile or
				other electronic means to the local board of health in the community in which
				the facility is located or contact the Department directly.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 300.000 - Reportable Diseases, Surveillance, and Isolation and Quarantine Requirements › Section 300.140 - Reporting of Animal Diseases with Zoonotic Potential by Veterinarians

Current through Register 1525, July 5, 2024
As required under M.G.L. c. 129, § 28 any veterinarian or
				local board of health with knowledge of the existence of a domestic animal
				affected with, or suspected to be affected with a contagious disease must
				report the disease to the Department of Agricultural Resources (DAR), Bureau of
				Animal Health. DAR will immediately notify the Department of any suspicion or
				occurrence of any such disease if it is potentially infectious to humans.
				Notwithstanding requirements to report such cases to DAR, veterinarians shall
				also report to the Department within 24 hours any case of anthrax, plague, West
				Nile virus infection, or Eastern equine encephalitis virus infection diagnosed
				in an animal. The Department will notify the local board of health of all such
				reports within 24 hours.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 300.000 - Reportable Diseases, Surveillance, and Isolation and Quarantine Requirements › Section 300.150 - Declaring a Disease or Condition Immediately Reportable, under Surveillance and/or Subject to Isolation and Quarantine

Current through Register 1525, July 5, 2024
In addition to the diseases and conditions listed in
				105 CMR 300.000, the
				Commissioner, as necessary to reduce morbidity and mortality in the
				Commonwealth, shall require the reporting, authorize the surveillance and/or
				establish isolation and quarantine requirements, on a time-limited basis, of
				confirmed and suspect cases of diseases or conditions which are newly
				recognized or recently identified or suspected to be a public health concern.
				Such declarations shall be initially authorized for a period of time not to
				exceed 12 months, at which point the declaration shall be reviewed to determine
				whether an extension of time, not to exceed 12 months, is necessary. If such
				additional time is necessary, the Department shall, during that time, determine
				whether the requirements should be continued pursuant to a revised regulation
				under
				105 CMR 300.000. Specific
				requirements of a declaration issued under 105 CMR 300.150 may be updated to
				reflect changing conditions and understanding of the disease or condition as
				new data becomes available.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 300.000 - Reportable Diseases, Surveillance, and Isolation and Quarantine Requirements › Section 300.160 - Diseases Reportable by Local Boards of Health to the Department

Current through Register 1525, July 5, 2024
Whenever there shall occur in any municipality, report of a
				case or condition listed in
				105 CMR 300.000, a case of
				unusual illness or cluster or outbreak of disease, including but not limited to
				suspected food poisoning, or an increased incidence of diarrheal and/or
				unexplained febrile illness, it shall be the duty of the local board of health
				to report immediately by secure electronic disease surveillance and case
				management system (MAVEN) designated and maintained by the Department and, if
				indicated by the Department, by telephone the existence of such an unusual
				disease, outbreak, cluster, or increased incidence of illness to the
				Department. Information contained in the report shall be defined by the
				Department and shall include full demographic, clinical, epidemiologic and
				laboratory information. The case's full demographic data, clinical data, and
				epidemiologic data shall be included in each report.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 300.000 - Reportable Diseases, Surveillance, and Isolation and Quarantine Requirements › Section 300.171 - Reporting of Antimicrobial Resistant Organisms and Cumulative Antibiotic Susceptibility Test Results (Antibiograms)

Current through Register 1525, July 5, 2024
(A) All
			 Laboratories shall report results indicating antimicrobial resistance in the
			 following organisms directly to the Department through secure electronic
			 laboratory reporting mechanisms, or other method, as defined by the Department.
			 Information shall include the name of a laboratory contact, the specified test
			 results, date of specimen collection, source of specimen, and the case's full
			 name, date of birth, sex, race and ethnicity, full address, telephone number,
			 and name of the ordering health care provider, when available.
Carbapenemase-producing and/or carbapenem-resistant
Enterobacteriacea
Neisseria gonorrhoeae
resistant to
				ceftriaxone
Vancomycin-resistant
Staphylococcus aureus
(VRSA)
Vancomycin-intermediate
Staphylococcus aureus
(VISA)
Invasive methicillin-resistant
Staphyloccus
				aureus
(MRSA)
Invasive penicillin-resistant
Streptococcus
pneumoniae
If antimicrobial resistance of an unexplained or novel nature
				is identified in any infectious organism, the laboratory must contact the
				Department within five business days.
(B) All hospitals shall report annual
			 cumulative antibiotic susceptibility test results (antibiograms). This report
			 shall include information specified by the Department and be sent in the manner
			 deemed acceptable by the Department.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 300.000 - Reportable Diseases, Surveillance, and Isolation and Quarantine Requirements › Section 300.172 - Submission of Selected Isolates and Diagnostic Specimens to the State Public Health Laboratory

Current through Register 1525, July 5, 2024
All laboratories shall submit the following directly to the
				State Public Health Laboratory for further examination.
Bacillus anthracis
isolates and suspect
				isolates
Brucella
sp. isolates and suspect
				isolates
Burkholderia mallei
isolates and suspect
				isolates
Burkholderia pseudomallei
isolates and suspect
				isolates
Carbapenem-resistant and carbapenemase producing
Enterobacteriacea
isolates
Campylobacter
sp. isolates
Clostridium botulinum
isolates and suspect
				isolates
Specimens obtained from human sources with indication or
				suspicion of eastern equine encephalitis (EEE) virus infection
Francisella tularensis
isolates and suspect
				isolates
Haemophilus influenzae
isolates from a usually
				sterile site
Influenza viruses diagnostic specimens or isolates known or
				suspected to contain antiviral resistant virus
Legionella
sp., isolates and suspect
				isolates
Listeria monocytogenes
isolates
Specimens with indication or suspicion of measles virus
				infection
Specimens with indication or suspicion of mumps virus
				infection
Mycobacterium tuberculosis
Neisseria gonorrhoeae
isolates
Neisseria meningitidis
isolates from a usually
				sterile site
Salmonella
sp. isolates
SARS-CoV-2 isolates
Shiga toxin producing organism isolates including
E.
				coli
O157, and any broths which test positive for shiga toxin
				producing organisms where the organism has not been isolated
Shigella
sp. isolates
Staphylococcus aureus
, vancomycin-intermediate
				and vancomycin-resistant isolates only
Streptococcus
				pneumoniae
isolates from a usually sterile site and only from
				individuals younger than 18 years old
Vibrio
sp. isolates
Specimens obtained from human sources with indication or
				suspicion of West Nile virus infection
Yersinia pestis
isolates and suspect
				isolates
Yersinia
sp. (non pestis) isolates
Organisms with antimicrobial resistance of a novel
				nature
Where necessary for the investigation, monitoring, control and
				prevention of diseases dangerous to the public health, the Department may
				require added specimens or isolates from organisms listed in
				105
				CMR 300.170 be submitted to the State Public
				Health Laboratory for further examination.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 300.000 - Reportable Diseases, Surveillance, and Isolation and Quarantine Requirements › Section 300.173 - Reporting of Certain Negative and Indeterminant Diagnostic Tests Associated with Ascertainment of Infection Status

Current through Register 1525, July 5, 2024
All laboratories performing examinations on any specimens
				derived from Massachusetts residents shall report directly to the Department
				through secure electronic laboratory mechanisms, or other method, as defined by
				the Department, within 24 hours, negative results of the following specific
				laboratory tests:
(1) Any test for
			 syphilis associated with a concurrent positive serologic test;
(2) Hepatitis C serologic and nucleic acid
			 amplification tests;
(3) Any
			 negative or indeterminate diagnostic test result for HIV infection associated
			 with a concurrent positive test;
(4) Any tests that are part of a panel of
			 diagnostic tests for vector-borne infections that are associated with a
			 concurrent positive result of one or more tests in the panel;
(5) Any tests that are part of a panel of
			 diagnostic tests for viral hepatitis infections that are associated with a
			 concurrent positive result of one or more tests in the panel;
(6) Any negative diagnostic test result for
			 SARS-CoV-2; and
(7) Any other
			 negative or indeterminate test as determined by the Department, when necessary
			 for the investigation, monitoring, control and prevention of diseases dangerous
			 to the public health.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 300.000 - Reportable Diseases, Surveillance, and Isolation and Quarantine Requirements › Section 300.174 - Laboratory Findings Indicative of Infectious Disease Reportable Directly to the Department by Point of Care Testing

Current through Register 1525, July 5, 2024
Physicians and other healthcare providers using point of care
				tests for diagnosis of infectious diseases must report test results to the
				Department when they are indicative of an infectious disease reportable
				directly to the Department by laboratories (per
				105
				CMR 300.170) , unless such point of care
				testing is subject to routine reflex testing by a supplementary or confirmatory
				testing the results of which would be reportable.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 300.000 - Reportable Diseases, Surveillance, and Isolation and Quarantine Requirements › Section 300.175 - Potential Exposures to Certain Infectious Agents in Clinical Laboratories and Research Settings Reportable Directly to the Department

Current through Register 1525, July 5, 2024
Any person who is in a supervisory position at a human or
				veterinary diagnostic or research laboratory located in Massachusetts who has
				knowledge that a human has had exposure to certain infectious agents in the
				laboratory, shall report the same immediately by telephone to the Department.
				These infectious agents include, but are not necessarily limited to,
Bacillus anthracis
(excluding Sterne strains),
Brucella suis
,
Brucella melitensis
,
Brucella abortus
,
Brucella canis
,
Brucella
sp. vaccine strains,
Burkholderia
				mallei
,
Burkholderia pseudomallei
,
Francisella tularensis
,
Neisseria
				meningitidis
, and
Yersinia pestis
In addition, bites, scratches or contact with body fluids from
				macaque monkeys shall be reported in the same manner.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 300.000 - Reportable Diseases, Surveillance, and Isolation and Quarantine Requirements › Section 300.181 - Reporting Work-related Disease Outbreaks

Current through Register 1525, July 5, 2024
Any physician or other health care provider who shall have
				knowledge of a work-related disease outbreak, regardless of whether or not the
				disease is included on the reportable disease list, shall report it immediately
				by telephone, in writing, by facsimile, or other electronic means to the
				Department.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 300.000 - Reportable Diseases, Surveillance, and Isolation and Quarantine Requirements › Section 300.182 - Joint Authority with Department of Labor and Workforce Development

Current through Register 1525, July 5, 2024
The Department recognizes that the Department of Labor and
				Workforce Development also has the authority, pursuant to M.G.L. c.149, §
				11, to require reporting of work-related diseases and conditions. In order to
				avoid duplicate reporting, the Department will, upon designation by the
				Department of Labor and Workforce Development, also serve as the agent of the
				Department of Labor and Workforce Development for collection of reports of
				work-related diseases and conditions required under M.G.L. c. 149, §
				11.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 300.000 - Reportable Diseases, Surveillance, and Isolation and Quarantine Requirements › Section 300.190 - Surveillance and Control of Diseases Dangerous to the Public Health

Current through Register 1525, July 5, 2024
The Department and local boards of health are authorized to
				conduct surveillance activities necessary for the investigation, monitoring,
				control and prevention of diseases dangerous to the public health. Such
				activities shall include, but need not be limited to:
(A) Systematic collection and evaluation of
			 morbidity and mortality reports. This includes the collection and analysis of
			 data derived from electronic health record systems.
(B) Investigation into the existence of
			 diseases dangerous to the public health to determine the causes and extent of
			 such diseases and to formulate prevention and control measures.
(C) Identification of cases and
			 contacts.
(D) Counseling and
			 interviewing individuals as appropriate to assist in positive identification of
			 exposed individuals and to develop information relating to the source and
			 spread of illness.
(E) Monitoring
			 the medical condition of individuals diagnosed with or exposed to diseases
			 dangerous to the public health.
(F)
			 Collection and/or preparation of data concerning the availability and use of
			 vaccines, immune globulins, insecticides and other substances used in disease
			 prevention and control.
(G)
			 Collection and/or preparation of data regarding immunity levels in segments of
			 the population and other relevant epidemiological data.
(H) Ensuring that diseases dangerous to the
			 public health are subject to the requirements of
			 105 CMR
			 300.200 and other proper control
			 measures.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 300.000 - Reportable Diseases, Surveillance, and Isolation and Quarantine Requirements › Section 300.191 - Access to Medical Records and Other Information

Current through Register 1525, July 5, 2024
(A) The Department or local boards of health
			 are authorized to obtain, upon request, from health care providers and other
			 persons subject to the provisions of
			 105 CMR 300.000, access to
			 medical records, including electronic health records, and other information
			 that the Department or the local board of health deems necessary to carry out
			 its responsibilities to investigate, monitor, prevent and control diseases
			 dangerous to the public health.
(B)
			 School nurses are authorized to obtain from health care providers the
			 immunization records or other immunization related information required for
			 school admission, without the authorization of the child's parent(s) or legal
			 guardian(s), as necessary to carry out the immunization requirements of M.G.L.
			 c. 76, § 15. Prior to requesting such records from the provider, school
			 nurses shall make a good faith effort to obtain the information from the
			 child's parent(s) or legal guardian(s) and shall notify them that the
			 information will be obtained from the health care provider pursuant to 105 CMR
			 300.191 if it is not provided in a timely manner by the parent(s) or
			 guardian(s). For purposes of the Health Insurance Portability and
			 Accountability Act (HIPAA), school nurses are hereby designated as public
			 health authorities and granted authority to obtain immunization information
			 from health care providers in accordance with
			 105 CMR 300.000 in order to
			 monitor and ensure compliance with the immunization requirements of M.G.L. c.
			 76, § 15.
(C) When, in the
			 determination of the commissioner, it is necessary for the investigation,
			 monitoring, control and prevention of diseases dangerous to the public health,
			 the Department may require health care providers and other persons subject to
			 the provisions of
			 105 CMR 300.000 report
			 specified information from medical records, including electronic health
			 records, to the Department.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 300.000 - Reportable Diseases, Surveillance, and Isolation and Quarantine Requirements › Section 300.192 - Surveillance of Diseases Possibly Linked to Environmental Exposures

Current through Register 1525, July 5, 2024
The Department is authorized to collect medical records and
				other identifiable information from health care providers and other persons
				subject to
				105 CMR 300.000, and/or
				prepare data, as detailed in
				105
				CMR 300.190 and
				300.191,
				on individuals evaluated for or diagnosed with the following diseases possibly
				linked to environmental exposures:
Amyotrophic lateral sclerosis (ALS);
Aplastic anemia;
Asthma;
Autism spectrum disorder (ASD);
Multiple sclerosis (MS);
Myelodysplastic syndrome (MDS);
Scleroderma;
Systemic lupus erythematosus.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 300.000 - Reportable Diseases, Surveillance, and Isolation and Quarantine Requirements › Section 300.193 - Surveillance of Injuries Dangerous to Public Health

Current through Register 1525, July 5, 2024
The Department is authorized to collect medical records and
				other identifiable information from health care providers and other persons
				subject to
				105 CMR 300.000, and/or
				prepare data, as detailed in
				105
				CMR 300.190 and
				300.191,
				related to the following types of injuries or causes of injuries:
Any mode of transportation;
Assaults or homicides;
Drownings;
Falls;
Fires;
Machinery;
Poisoning, including, but not limited to, drug overdose;
Spinal cord injuries;
Strikes by/against another object or person;
Suffocation;
Suicides, attempted suicides, or self-inflicted wounds;
Traumatic amputations;
Traumatic brain injuries;
Weapons;
Work-related injuries.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 300.000 - Reportable Diseases, Surveillance, and Isolation and Quarantine Requirements › Section 300.210 - Procedures for Isolation and Quarantine

Current through Register 1525, July 5, 2024
(A)
Scope
.
(1) The
			 Department through an authorized agent shall, and local boards of health are
			 encouraged to strongly comply with the provisions of 105 CMR 300.210(B) through
			 (I) when implementing isolation or quarantine.
(2) The procedures set forth in 105 CMR
			 300.210(B) through (I) are applicable to isolation and quarantine of persons in
			 the population at large, but do not apply to persons in the custody of
			 correctional facilities operated by the Department of Correction, persons in
			 the custody of county houses of correction, persons in the custody of city or
			 town jails, or to youth detained by or committed to the Department of Youth
			 Services.
(3) Notwithstanding 105
			 CMR 300.210(A)(1) and (2), the Department and local boards of health shall
			 follow the procedures set forth in M.G.L. c. 111, §§ 94A through 94H
			 when isolating individuals with active tuberculosis who are unwilling or unable
			 to accept proper medical treatment and who thereby pose a serious danger to
			 public health.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 301.000 - Cancer Registry › Section 301.001 - Purpose

Current through Register 1525, July 5, 2024
The purpose of
				105 CMR
				301.000 is to facilitate the maintenance of the Cancer
				Registry established by the Massachusetts Department of Public Health pursuant
				to M.G.L. c. 111, § 111B, and in particular to:
(A) Declare those cases of malignant disease
			 and benign brain-related tumor disease which are required to be reported to the
			 Department of Public Health for inclusion in the Cancer Registry;
(B) Declare other necessary and appropriate
			 information concerning reported cases which is required to be reported to the
			 Department;
(C) Declare those
			 persons, facilities and agencies which are required to report cases of
			 malignant disease and benign brain-related tumor disease and other necessary
			 and appropriate information to the Department;
(D) Require that the Cancer Registry of the
			 Department of Public Health be given access to such part of patients' medical
			 records as are necessary to verify the accuracy of reported information;
			 and
(E) Require that, consistent
			 with M.G.L. c. 111, § 111B, the Department of Public Health maintain the
			 confidentiality of reported information and restrict releases to only
			 specifically approved purposes.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 301.000 - Cancer Registry › Section 301.005 - Definitions

Current through Register 1525, July 5, 2024
As used in
				105 CMR
				301.000, the following words have the following
				meanings:
Benign Brain-related Tumors
. A tumor
				(neoplasm) that grows in place with little or no potential to spread (invade)
				to other tissue. Tumors included in this definition occur in the following body
				sites, meninges, brain, spinal cord, cranial nerves, and other nerves of the
				central nervous system, pituitary gland, pineal gland, and craniopharyngeal
				duct as listed in the most recently amended
International
				Classification of Diseases for Oncology
(ICD-O) or
Classification of Tumours
series, published by the World
				Health Organization.
Cancer Registry
. The Cancer Registry
				established by the Massachusetts Department of Public Health pursuant to M.G.L.
				c.111, § 111B.
Department
. The Department of Public
				Health.
Health Care Facility
. Any facility or
				institution, whether public or private, proprietary or not for profit
				including, but not limited to, hospitals, including general hospitals,
				free-standing radiation therapy and outpatient oncology centers, nursing homes,
				hospices, all pathology and cytology laboratories, including hospital
				laboratories, health maintenance organizations and other outpatient facilities
				such as free-standing surgical centers, which diagnose, evaluate or provide
				cancer treatment to cancer patients.
Health Care Provider
. Any physician,
				nurse practitioner, physician assistant, dentist, podiatrist, chiropractor, or
				osteopath who is licensed to practice in the Commonwealth of Massachusetts and
				who diagnoses a case of malignant disease or benign brain-related tumor,
				evaluates a previously diagnosed case of malignant disease or benign
				brain-related tumor, or provides cancer treatment to a cancer patient.
Malignant Disease
. Any malignant
				(
in situ
or invasive) disease which is listed in the most
				recently amended
International Classification of Diseases for Oncology
				(ICD-O) or Classification of Tumours
series, published by the World
				Health Organization, excluding
in-situ
carcinomas of the
				uterine cervix and basal, epithelial, papillary and squamous cell carcinomas of
				the skin, but including carcinomas of the vermilion border of the lip, vulva,
				labia, penis, scrotum and anus.
Practitioner
means any physician,
				medical examiner, dentist, podiatrist, chiropractor, or osteopath practicing in
				the Commonwealth of Massachusetts.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 301.000 - Cancer Registry › Section 301.010 - Required Reporting

Current through Register 1525, July 5, 2024
(A) A health care
			 facility shall report all cases of malignant disease and benign brain-related
			 tumor disease that are diagnosed, evaluated, treated, medically supported or
			 palliated at their facility. Each case of malignant disease and benign
			 brain-related tumor disease within the Commonwealth of Massachusetts shall be
			 reported to the Cancer Registry with information specified in
			 105
			 CMR 301.015 and in accordance with the
			 current Cancer Registry Data Collection Manual as specified in
			 105
			 CMR 301.020.
(B) A health care provider who diagnoses,
			 evaluates, treats, medically supports or palliates a case of malignant disease
			 or benign brain-related tumor disease shall report such case to the Cancer
			 Registry as specified in 105 CMR 301.010(A), except when the health care
			 provider knows that a health care facility has reported or will report the case
			 to the Cancer Registry.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 301.000 - Cancer Registry › Section 301.015 - Information Required to Be Reported

Current through Register 1525, July 5, 2024
Each report required by
				105
				CMR 301.010 shall include all the data
				elements specified in the Cancer Registry Data Collection Manual, as described
				in 105 CMR 301.020, in the
				following data categories:
(A) Patient
			 information and demographics
(B)
			 Provider and facility information
(C) Cancer information
(D) Extent of disease at diagnosis;
(E) First course of treatment; and
(F) Any further demographic, diagnostic, or
			 treatment information requested by the Cancer Registry concerning any person
			 now or formerly receiving services, diagnosed as having or having had a
			 malignant disease or benign brain-related tumor disease.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 301.000 - Cancer Registry › Section 301.017 - Data Collection Manual

Current through Register 1525, July 5, 2024
The Cancer Registry maintains a data collection manual that
				identifies the discrete data items to be reported under
				105 CMR
				301.015 and the cases required to be reported
				under
				105 CMR
				301.010, which is available to all reporting
				facilities. The manual willbe revised periodically in accordance with national
				cancer registration standards and Commonwealth-specific
				requirements.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 301.000 - Cancer Registry › Section 301.020 - Data Collection Manual

Current through Register 1525, July 5, 2024
The Cancer Registry maintains the Cancer Registry Data
				Collection Manual, which identifies the discrete data items to be reported
				under
				105
				CMR 301.015 and the cases required to be
				reported under
				105
				CMR 301.010. The Cancer Registry Data
				Collection Manual is available to all reporting facilities.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 301.000 - Cancer Registry › Section 301.025 - Report Form

Current through Register 1525, July 5, 2024
Each report of a case of malignant disease and benign
				brain-related tumor disease required to be reported by
				105
				CMR 301.010 together with all accompanying
				information required to be reported by
				105
				CMR 301.015 and
				301.020, that is reported by
				a health care facility shall be reported in an electronic format approved by
				the Department. Health care providers shall report either in an electronic
				format approved by the Department or on a report form approved by the
				Department.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 301.000 - Cancer Registry › Section 301.030 - Time for Reporting

Current through Register 1525, July 5, 2024
All information required to be reported by
				105
				CMR 301.010,
				301.015 and
				301.020 shall be sent to the
				Cancer Registry within 180 days of the date of diagnosis, or date of first
				contact when diagnosis, evaluation, treatment, medical support or palliative
				services occurred elsewhere. Any missing information or changes to previously
				reported information shall be sent to the Cancer Registry as soon as the new
				information becomes available.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 301.000 - Cancer Registry › Section 301.035 - Quality Assurance and Case Ascertainment

Current through Register 1525, July 5, 2024
(A) For the purpose of assuring the accuracy
			 and completeness of submitted data and to ensure that all cases of malignant
			 disease and benign brain-related tumor disease are reported, each health care
			 facility and health care provider shall allow authorized Cancer Registry staff
			 or agents to inspect and copy such parts of patients' medical records, paper
			 and electronic, as are necessary to assure accurate and complete reporting and
			 to identify any missing required reports.
(B) Each health care facility, health care
			 provider, and pharmacist licensed in accordance with M.G.L. c. 112, § 24,
			 shall provide copies of the following records to the Cancer Registry upon
			 request:
(1) Reports of all tissue analyses
			 which have been performed for the purpose of determining the presence or
			 absence of malignant disease and benign brain-related tumor disease;
(2) Reports (including X-rays) of
			 radiological examinations performed for the purpose of determining the presence
			 or absence of malignant disease and benign brain-related tumor
			 disease;
(3) Reports of diagnoses
			 of malignant disease and benign brain-related tumor disease, and notations of
			 the reasons for such diagnoses, including both primary clinicians' reports and
			 consultation reports;
(4) Pharmacy
			 records for prescriptions relating to cancer treatment; and
(5) Those portions of medical records which
			 contain the specific information required to be reported pursuant to
			 105
			 CMR 301.015.